| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

,
Lezanne Ooi,
Lukasz Kozera,
Edward White, and
Ian C. Wood*
Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom
Received 14 February 2007/ Accepted 9 March 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
-skeletal actin (Acta1), potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channels 2 and 4 (Hcn2 and Hcn4), and voltage-gated calcium channel subunit alpha Cav3.2 (Cacna1h) (26, 43). Levels of BNP and ANP are particularly important, since increased levels of these peptides in circulation are clinical indicators of the severity of hypertrophy (8, 29, 38, 61). In adult ventricular myocytes, expression of both BNP and ANP is increased in cardiac hypertrophy, and as they are secreted via the constitutive secretory pathway, increased expression results in increased levels of circulating peptides (38, 52). Binding sites for REST (RE1 sites) have been identified in both Nppb and Nppa gene regulatory regions, and a role for REST in repression of these genes has been identified in ventricular myocytes (27, 28, 43). Since removal of REST function within the heart in transgenic mice results in increased ANP and BNP expression and cardiac hypertrophy, it has been proposed that repression of these genes by REST is an important component of normal heart function (28). The molecular mechanisms involved in REST repression of Nppb and Nppa genes, however, are not known. REST is able to recruit two independent corepressor complexes through N-terminal and C-terminal repression domains (2, 15, 21, 42, 49, 59). Via its N-terminal repression domain, REST interacts with the mSin3 corepressor complex, and repression via the N terminus is associated with class I (15, 21, 42, 49) and class II (40) histone deacetylase (HDAC) activity. The C-terminal repression domain of REST interacts with the corepressor CoREST, which, like mSin3, is part of a larger complex (2, 16, 22, 65). The CoREST corepressor complex contains HDAC1, HDAC2, and lysine-specific histone demethylase 1 (LSD1, also known as BHC110), which represses transcription by demethylating histone H3 lysine 4 (H3K4) (16, 22, 54, 65). The significance of, and the requirement for, two independent repression domains in REST is not entirely clear. When fused to a Gal4 DNA binding domain, both the N- and C-terminal repression domains are able to independently repress transcription of a reporter gene containing Gal4 binding sites (59), and deletion of either domain from the full-length protein results in some loss of repressor activity, but repressor activity is lost completely only with the removal of both domains (4). REST is able to recruit both mSin3 and CoREST to the Scn2a2 (Nav1.2) RE1 site in L6 and JTC-19 cells (4, 6); however, the mechanisms of REST repression appear to be gene and cell type dependent. Scn2a2 expression was derepressed by the HDAC inhibitor trichostatin A (TSA) in HEK293 and JTC-19 cells but not in Rat-1 and Neuro-2a cells (4, 6, 34, 49). Additionally, inhibition of CoREST recruitment is sufficient to inhibit Scn2a2 but not Stmn2 (SCG10) gene expression in Rat-1 cells (34). Most of the studies of REST have focused on silencing of RE1 genes in nonneuronal cells or repression of RE1 genes in neurons (5, 9, 10, 34, 39, 45, 67). In cardiac myocytes, REST repression of Nppa is associated with decreased histone acetylation, though whether this is due to recruitment of HDAC activity by the N- or C-terminal repression domains is not clear (27). In response to the hypertrophy-inducing stimulus endothelin-1 (ET-1), adult rat ventricular myocytes show increased expression of Nppb and Nppa mRNA.
Here we show that continued expression of REST using adenovirus delivery is sufficient to prevent ET-1-induced increases in expression of Nppb and Nppa. In a rat ventricular myocyte cell line (H9c2), REST is recruited to and represses the expression of the Nppb and Nppa genes, and inhibition of REST function results in increased Nppb and Nppa expression. Both ET-1 treatment of adult ventricular myocytes and inhibition of REST in H9c2 cells are associated with increases in both histone H4 acetylation and dimethyl H3K4. We show that recruitment of HDAC activity by REST is not sufficient to repress Nppb or Nppa, and we provide evidence that demethylation of H3K4 is a vital component of REST repression. Expression of ectopic REST lacking either the N- or the C-terminal repression domain leads to partial derepression of Nppb transcription and associated chromatin changes, suggesting that both domains are required for repression of Nppb in these cells. Conversely, our data suggest that either domain alone is able to repress Nppa transcription and maintain a repressed chromatin state at the Nppa promoter. This is the first study to demonstrate a functional requirement for both repression domains of REST to regulate the levels of an actively transcribed gene, and it provides insights into the chromatin changes that may be important in cardiac hypertrophy.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture. H9c2 cells obtained from the European Collection of Cell Cultures were cultured in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% (vol/vol) fetal calf serum, 2 mM glutamine, streptomycin (10 g/liter), and penicillin (10 g/liter) at 37°C under 5% CO2. Cells were incubated with 300 nM TSA (Wako) or 1 mM 5'-deoxy-5'-methyl-thioadenosine (MTA; Sigma) for 48 h prior to isolation of RNA and reverse transcription-PCR (RT-PCR) analysis.
Immunohistochemistry. H9c2 cells were fixed and stained using the REST antiserum R2174 (62) (1:1,000) or preimmune serum. Staining was visualized by fluorescence using a fluorescein isothiocyanate (FITC)-conjugated anti-rabbit secondary antibody (1:100; Santa Cruz). Nuclei were counterstained using 4',6'-diamidino-2-phenylindole (DAPI).
RT-PCR. Total RNA was isolated from H9c2 cells using Tri reagent (Sigma) and reverse transcribed using oligo(dT), random primers, and the Moloney murine leukemia virus reverse transcriptase RNase H() point mutant (Promega). PCR was performed using the following oligonucleotide primers: for cyclophilin, sense primer 5'-ACCCCACCGTGTTCTTCGAC and antisense primer 5'-TGGACTTGCCACCAGTGCCA; for Nppb, sense primer 5'-GACTCCGGCTTCTGATCTG and antisense primer 5'-ACTGTGGCAAGTTTGTGCTG; for. Nppa, sense primer 5'-CTGCTTTCTGAAAGGGGTGA and antisense primer 5'-CGGTGTGTCACACAGCTTGG; for Rest (rat), sense primer 5'-ACTTTGTCCTTACTCAAGTTCTCAG and antisense primer 5'-ATGGCGGGTTACTTCATGTT; for REST (human), sense primer 5'-CGAACTCACACAGGAGAACG and antisense primer 5'-GAGGCCACATAATTGCACTG. Quantitative PCR was performed using SYBR green I incorporation, measured using an iCycler iQ system (Bio-Rad). All reactions were performed in duplicate alongside negative controls containing RNA as a template.
Adenovirus construction and amplification. Adenoviruses containing either full-length REST or the DNA binding domain (amino acids 234 to 437) of REST (dominant-negative REST [DN-REST]) have been described previously (11, 62). A REST sequence encoding either amino acids 1 to 1097 (REST), 73 to 1097 (C-REST), or 1 to 1017 (N-REST) was amplified by PCR and cloned into pAdTrack-CMV. The resulting plasmids were linearized with PmeI and electroporated into competent Escherichia coli BJ5183 containing the pAdEasy-1 plasmid (19). Recombinants were selected for by growth on kanamycin. The resulting adenovirus plasmids were purified, linearized with PacI, and transfected into packaging HEK293 cells to produce adenovirus particles. Viral amplification was achieved via four rounds of infection, and the virus was purified through cesium chloride gradients using standard protocols. H9c2 cells were infected using approximately 1 x 1012 virus particles/ml and were harvested for analysis after 48 h.
Gel shift assays.
DNA fragments containing the rat Nppb and Nppa RE1 sites were amplified using the following primers: for Nppb, sense primer 5'-CGCGAAGCTTGGCAGGGTATCAGAGTGGTT and antisense primer 5'-CGCGAAGCTTAGTTAGCACCCACCATCACC; for Nppa, sense primer 5'-CGCGAAGCTTGGCCTTACCTCTCCCACTCT and antisense primer 5'-CGCGAAGCTTGGTGACAGAAAGGAGCCAAA. PCR products were digested with HindIII, and [
-32P]dATP was incorporated by Klenow fill-in. Probes were run on a 4% polyacrylamide gel and purified. Nuclear protein was prepared from H9c2 cells using the procedure described by Andrews and Faller (3) and was quantified using a DC protein assay kit (Bio-Rad). Protein (20 µg for uninfected and 6 µg for infected H9c2 cells) was preincubated on ice, with or without competitor DNA, for 20 min in 19 µl of a solution containing 20 mM HEPES (pH 7.9), 100 mM KCl, 5 mM MgCl2, 8% (vol/vol) glycerol, and 1 µg of calf thymus DNA. Approximately 10,000 to 20,000 cpm of radioactive probe was added to each reaction mixture and incubated for 20 min at room temperature. For supershift experiments, 2 µg of anti-REST (P18; Santa Cruz) or anti-Sp1 (H-225; Santa Cruz) antibody was added, and reaction mixtures were incubated for a further 30 min at room temperature. Reactions were run on 0.5x Tris-borate-EDTA polyacrylamide gels, fixed, dried, and exposed to Biomax X-ray film (Kodak) for 16 h. Complementary oligonucleotides for the following sites (with sequences given in parentheses) were annealed and used for competition experiments: Chrm4 RE1 (5'-GTACGGAGCTGTCCGAGGTGCTGAATCTGCCT), Nppb RE1 (5'-GGTGATCAGAACCATGGACACTACCA), Nppa RE1 (5'-AAACTTCAGCACCACGGACAGACGCTG), and Sp1 (5'-AATTCCCCGAGGGGCGCCTAGTCCCCATG).
Chromatin immunoprecipitation (ChIP). Anti-REST (R2174 [62]), anti-Myc (Sigma), anti-acetylated H4 (Abcam), and anti-dimethyl H3K4 (Abcam) antibodies were used to immunoprecipitate cross-linked chromatin. H9c2 cells were cross-linked with 0.37% formaldehyde for 10 min at room temperature. Glycine was added to a final concentration of 0.125 M to terminate the cross-linking reaction. Cells were harvested, washed with phosphate-buffered saline, resuspended in cell lysis buffer (10 mM Tris-HCl [pH 8.0], 10 mM NaCl, 0.2% NP-40, 10 mM sodium butyrate, 50 µg/ml phenylmethylsulfonyl fluoride [PMSF], 1 µg/ml leupeptin), and incubated on ice for 10 min. After centrifugation, nuclei were resuspended in 1.2 ml of nuclear lysis buffer (50 mM Tris-HCl [pH 8.1], 10 mM EDTA, 1% sodium dodecyl sulfate, 10 mM sodium butyrate, 50 µg/ml PMSF, 1 µg/ml leupeptin) and incubated on ice for 10 min before addition of 0.72 ml of immunoprecipitation dilution buffer (20 mM Tris-HCl [pH 8.1], 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.01% sodium dodecyl sulfate, 10 mM sodium butyrate, 50 µg/ml PMSF, 1 µg/ml leupeptin). Fixed chromatin was fragmented by sonication to an average size of 500 to 700 bp. Sonicated extracts were precleared with protein G-Sepharose and chromatin immunoprecipitated using 4 µg of antibody or 10 µl of crude serum. Cross-links were reversed, and protein was removed by digestion with proteinase K and phenol extraction. Purified DNA was resuspended in 50 µl of Tris-EDTA, pH 8, and 2 µl was used for quantitative PCR. Products were quantified using SYBR green I incorporation, measured using an iCycler iQ system (Bio-Rad) with the following primers: for the Nppa promoter, sense primer 5'-GTTGGCTTCCTGGCTGACT and antisense primer 5'-CACCCCCACCCTAGATGTC; for Nppa RE1, sense primer 5'-TTTGGCTCCTTTCTGTCACC and antisense primer 5'-CACACACACACACACACACG; for Nppb RE1, sense primer 5'-TTACAGGTTCGAGGACACTC and antisense primer 5'-GCTTATGGGGTGACTCATC; for the control, sense primer 5'-TCCTCACCTGGACACCCTAC and antisense primer 5'-ACGTAGCAGAGCCAGTAGCC. A minimum of three independent experiments were performed, and significance was analyzed using a Student t test.
| RESULTS |
|---|
|
|
|---|
|
|
|
REST repression is mediated in part by histone deacetylation. Changes in gene expression are often brought about via covalent modifications of histones, resulting in altered chromatin structure and a change in the ability to recruit other transcriptional regulatory proteins. We investigated changes in histone modifications that are associated with derepression of Nppb and Nppa transcription mediated by DN-REST. The Nppb RE1 site is located approximately 500 bp 5' to the transcription start site (43) (Fig. 4a), and thus we were able to use the Nppb RE1 primers to interrogate histone modifications at the promoter of the Nppb gene. The Nppa RE1 site, however, is located in the 3' untranslated region (27) (Fig. 4a), and in order to interrogate the histone modifications at the Nppa promoter, we designed specific primers located 500 bp from the Nppa transcription start site. Since REST is known to repress transcription via the recruitment of HDACs (15, 21, 42, 49), and HDAC activity is thought to play a role in Nppa repression (27, 28, 40), we used an antibody to acetylated histone H4 (AcH4) in a ChIP assay to examine the level of histone H4 acetylation at the Nppb and Nppa genes in the presence and absence of REST in H9c2 cells. Displacement of REST by DN-REST resulted in a significant increase in H4 acetylation at both the Nppb and Nppa promoter regions (10.4- and 7.3-fold, respectively) (Fig. 4b). Interestingly the Nppa RE1 region showed only a modest (1.6-fold) increase in H4 acetylation levels, though the basal level of acetylation did appear greater than that for either the Nppb or Nppa promoter region (Fig. 4b). Control DNA did not show any change in H4 acetylation levels in response to DN-REST (Fig. 4b). These data indicate that removal of REST from the Nppb and Nppa genes results in increased histone acetylation at the promoters, and they suggest that HDACs recruited by REST play a role in repressing Nppb and Nppa transcription by antagonizing histone acetyltransferases. Although it has previously been reported that HDAC activity is involved in Nppa repression (27, 28, 40), it is not known if other enzyme activities recruited by REST are also required. To test if HDAC activity alone was sufficient for the observed repression of Nppb and Nppa by REST, we examined the effects on Nppb and Nppa expression of removing REST in the presence of TSA. If REST-mediated repression occurs solely via HDAC activity, then treatment with TSA should result in derepression of Nppb and Nppa, and subsequent displacement of REST would have no additional effect. Conversely, any repression mediated by REST in the presence of TSA must involve mechanisms other than recruitment of HDAC activity. Treatment of H9c2 cells with TSA alone resulted in some derepression of Nppb and Nppa transcription; however, displacement of REST in the continued presence of TSA resulted in further increases in Nppb and Nppa transcript levels (10.2- and 2.1-fold, respectively, above that with TSA alone) (Fig. 4c). These data indicate that REST represses Nppb and Nppa transcription using mechanisms additional to HDAC activity.
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In addition to their many similar features, there are also differences between Nppb and Nppa promoters. The Nppb promoter is more similar to promoters expressed in erythroid cells due to the presence of binding sites for the erythroid kruppel-like factor zinc finger proteins and AP1 motifs (36). The Nppa promoter contains several motifs that are also found in other cardiac genes, including the CArG serum response element and several E-boxes that recruit a dHAND/MEF2c complex (55, 66). One potential candidate for an Nppa-specific factor is the transcriptional repressor Jumonji, which is important for repressing Nppa expression in ventricular myocytes (24, 31). The continued presence of Jumonji in the absence of REST would provide one explanation of why the Nppa promoter appears less active than the Nppb promoter in H9c2 cells. Many of the transcription factors that regulate Nppb and Nppa do so in a combinatorial manner. For example, serum response factor activates both Nppb and Nppa transcription, but its function is inhibited by interactions with the homeobox-containing protein, HOP (55). GATA-4 associates with Nkx2.5 to enhance transcription, though this is antagonized by FOG-2 (33), while activation by MEF2 is antagonized by Twist (57). Some of the transcription factors that regulate the Nppb and Nppa promoters (for example, GATA-4) are known to recruit histone acetyltransferase activity, thus providing a direct antagonism of any REST repression mediated by HDAC activity.
Potential roles for the N- and C-terminal repression domains of REST have not been previously studied for cardiac cells; however, different roles have been suggested for these domains in the regulation of RE1-containing genes in other cell types. For example, REST repression of the Scn2a2 promoter in Rat-1 cells has been reported to involve CoREST but not HDAC recruitment (34), while in C6, JTC-19, and HEK293 cells, HDAC recruitment and activity are important (4, 6, 21). REST repression of the Chrm4, Gria2 (GluR2), and Grin1 (NMDAR1) genes also involves HDAC activity (6, 21, 42, 49, 62). Repression of the Stmn2 gene is achieved by HDAC activity in 3T3 NIH cells but requires a combination of HDAC activity and CoREST-recruited DNA methylase in Rat-1 cells (34, 42). In Neuro-2a cells, REST repression of the Chrm4 promoter is mediated via HDAC activity, but repression of the Scn2a2 promoter is not (49). Work with Rat-1 cells led to the proposal that recruitment of the CoREST complex by the C-terminal repression domain is important for long-term gene silencing, while recruitment of the mSin3 complex is important for transient repression (34). Here we show that recruitment of histone demethylase activity by the C-terminal domain does not mediate gene silencing of Nppb or Nppa in H9c2 cells but is also important for transient repression of Nppb transcription.
The changes in chromatin modifications that we see in response to displacement of functional REST occur at the proximal promoter regions (Fig. 4b and 5a). The Nppb RE1 site is only 500 bp from the Nppb transcriptional start site, and because the genomic fragments from our ChIP experiments have an average size of 600 bp, we are not able to resolve these locations. The Nppa RE1 site, however, is located in the 3' untranslated region of the Nppa gene, 2 kb from the transcription start site (27), allowing us to resolve these locations in our ChIP assay. It has been suggested that REST is able to act over large distances, since RE1 sites have been identified within introns and in regions distal to promoters of genes (7, 23, 34). Our studies provide the first data to show that REST is able to influence the chromatin modifications of promoter regions located some distance from an RE1 site. The level of histone acetylation at the Nppb and Nppa promoters will be defined by combinatorial actions of histone acetyltransferase and HDAC activities recruited by the transcription factors present. Similar levels of AcH4 are present at the promoter regions of Nppb and Nppa in H9c2 cells (Fig. 4b); however, expression of DN-REST results in a greater increase in AcH4 levels at the Nppb promoter (10.4-fold compared with 7.3-fold for Nppa [Fig. 4b]). These data indicate that in H9c2 cells, more histone acetyltransferase activity is recruited to the Nppb than to the Nppa gene. Removal of either REST repression domain results in some increase in AcH4 levels at the Nppb but not the Nppa promoter (Fig. 7a), suggesting that a single HDAC-containing complex is sufficient to antagonize the acetyltransferases present at the Nppa gene but not at the Nppb gene. Perhaps more interestingly, only one of the repression domains of REST, the C-terminal domain, has been associated with histone demethylase activity (22, 54, 65), yet removal of either repression domain results in increased methylated H3K4 at the Nppb promoter (Fig. 7b). Though we cannot rule out the possibility of recruitment of histone demethylase activity as part of the mSin3 complex, the mSin3 complex has been widely studied, and no evidence for associated histone demethylation has been reported. Removal of histone acetylation by HDACs has been shown to be required to stimulate the demethylase activity of LSD1 (30). Thus, increased acetylation levels may impair LSD1 activity, resulting in increased H3K4 methylation levels. Another possibility is that increased histone acetylation seen at the Nppb promoter leads to increased recruitment of a histone methyltransferase protein via a protein containing a bromodomain (which recognizes acetylated lysines). Although such recruitment does not need to be direct, it is interesting that two histone methyltransferase proteins, MLL1 and ASH1, contain bromodomains and that MLL1 methylates H3K4 (37, 41). Furthermore, recruitment of MLL1 has been implicated in antagonizing REST function during neuronal differentiation (63). Increased histone acetylation is also important as a first step in the induction of the beta interferon gene and is required solely for the recruitment of the SWI/SNF complex, which subsequently remodels the local chromatin, resulting in increased transcription (1). However, increased acetylation also results in increased recruitment of REST via the chromatin-remodeling enzyme BRG1, suggesting that increased acetylation may also lead to increased repression (44).
In addition to recruitment of HDAC and histone demethylase activity, REST is able to repress expression by recruiting a histone methyltransferase, G9a, which methylates H3K9 (48, 58). It is unlikely that G9a activity is responsible for continued Nppa repression, since G9a is recruited by the C-terminal domain of REST (48); thus, G9a would not be recruited by our N-REST construct. REST has also been suggested to recruit RNA polymerase C-terminal domain phosphatases, which also act to repress transcription (64). It is not known if these C-terminal domain phosphatases are recruited directly by REST or which part of the REST protein is responsible for their recruitment. It is possible that our C-REST and N-REST proteins are able to recruit these C-terminal domain phosphatases, which are expressed in the heart (64), and their activity may contribute to continued Nppa repression (Fig. 6b). However, given that C-terminal domain phosphorylation of RNA polymerase is a fundamental event in gene transcription, we would expect any recruited C-terminal domain phosphatases to also repress Nppb transcription.
In summary, we provide evidence that both repression domains of REST are required for effective repression of Nppb transcription in H9c2 cells and that this is achieved by a combination of targeted histone deacetylation and histone demethylation. Conversely, either REST domain retains sufficient repression activity to maintain repression of Nppa, which is driven from a less active promoter. These data suggest that the actions of multiple chromatin-modifying complexes are important in maintaining appropriate cardiac gene expression.
| ACKNOWLEDGMENTS |
|---|
We thank Rory Johnson and Mariusz Mucha for critical reading of the manuscript.
| FOOTNOTES |
|---|
Published ahead of print on 19 March 2007. ![]()
A.J.B. and L.O. contributed equally to this work. ![]()
Present address: Department of Cardiovascular Sciences, Cardiology Group, University of Leicester, Glenfield General Hospital, Leicester LE3 9QP, United Kingdom. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Andres, M. E., C. Burger, M. J. Peral-Rubio, E. Battaglioli, M. E. Anderson, J. Grimes, J. Dallman, N. Ballas, and G. Mandel. 1999. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc. Natl. Acad. Sci. USA 96:9873-9878.
3. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
4. Ballas, N., E. Battaglioli, F. Atouf, M. E. Andres, J. Chenoweth, M. E. Anderson, C. Burger, M. Moniwa, J. R. Davie, W. J. Bowers, H. J. Federoff, D. W. Rose, M. G. Rosenfeld, P. Brehm, and G. Mandel. 2001. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31:353-365.[CrossRef][Medline]
5. Ballas, N., C. Grunseich, D. D. Lu, J. C. Speh, and G. Mandel. 2005. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121:645-657.[CrossRef][Medline]
6. Belyaev, N. D., I. C. Wood, A. W. Bruce, M. Street, J. B. Trinh, and N. J. Buckley. 2004. Distinct RE-1 silencing transcription factor-containing complexes interact with different target genes. J. Biol. Chem. 279:556-561.
7. Bruce, A. W., I. J. Donaldson, I. C. Wood, S. A. Yerbury, M. I. Sadowski, M. Chapman, B. Gottgens, and N. J. Buckley. 2004. Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc. Natl. Acad. Sci. USA 101:10458-10463.
8. Burnett, J. C., Jr., P. C. Kao, D. C. Hu, D. W. Heser, D. Heublein, J. P. Granger, T. J. Opgenorth, and G. S. Reeder. 1986. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:1145-1147.
9. Calderone, A., T. Jover, K. M. Noh, H. Tanaka, H. Yokota, Y. Lin, S. Y. Grooms, R. Regis, M. V. Bennett, and R. S. Zukin. 2003. Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 23:2112-2121.
10. Chen, Z. F., A. J. Paquette, and D. J. Anderson. 1998. NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat. Genet. 20:136-142.[CrossRef][Medline]
11. Cheong, A., A. J. Bingham, J. Li, B. Kumar, P. Sukumar, C. Munsch, N. J. Buckley, C. B. Neylon, K. E. Porter, D. J. Beech, and I. C. Wood. 2005. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol. Cell 20:45-52.[CrossRef][Medline]
12. Chong, J. A., J. Tapia-Ramirez, S. Kim, J. J. Toledo-Aral, Y. Zheng, M. C. Boutros, Y. M. Altshuller, M. A. Frohman, S. D. Kraner, and G. Mandel. 1995. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80:949-957.[CrossRef][Medline]
13. Durocher, D., C. Grepin, and M. Nemer. 1998. Regulation of gene expression in the endocrine heart. Recent Prog. Horm. Res. 53:7-23.[Medline]
14. Gill, G., and M. Ptashne. 1988. Negative effect of the transcriptional activator GAL4. Nature 334:721-724.[CrossRef][Medline]
15. Grimes, J. A., S. J. Nielsen, E. Battaglioli, E. A. Miska, J. C. Speh, D. L. Berry, F. Atouf, B. C. Holdener, G. Mandel, and T. Kouzarides. 2000. The co-repressor mSin3A is a functional component of the REST-CoREST repressor complex. J. Biol. Chem. 275:9461-9467.
16. Hakimi, M. A., D. A. Bochar, J. Chenoweth, W. S. Lane, G. Mandel, and R. Shiekhattar. 2002. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc. Natl. Acad. Sci. USA 99:7420-7425.
17. Harrison, S. M., E. McCall, and M. R. Boyett. 1992. The relationship between contraction and intracellular sodium in rat and guinea-pig ventricular myocytes. J. Physiol. 449:517-550.
18. He, Q., M. Mendez, and M. C. LaPointe. 2002. Regulation of the human brain natriuretic peptide gene by GATA-4. Am. J. Physiol. Endocrinol. Metab. 283:E50-E57.
19. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
20. Houweling, A. C., M. M. van Borren, A. F. Moorman, and V. M. Christoffels. 2005. Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Cardiovasc. Res. 67:583-593.
21. Huang, Y., S. J. Myers, and R. Dingledine. 1999. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat. Neurosci. 2:867-872.[CrossRef][Medline]
22. Humphrey, G. W., Y. Wang, V. R. Russanova, T. Hirai, J. Qin, Y. Nakatani, and B. H. Howard. 2001. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 276:6817-6824.
23. Johnson, R., R. J. Gamblin, L. Ooi, A. W. Bruce, I. J. Donaldson, D. R. Westhead, I. C. Wood, R. M. Jackson, and N. J. Buckley. 2006. Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication. Nucleic Acids Res. 34:3862-3877.
24. Kim, T. G., J. Chen, J. Sadoshima, and Y. Lee. 2004. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol. Cell. Biol. 24:10151-10160.
25. Kimes, B. W., and B. L. Brandt. 1976. Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98:367-381.[CrossRef][Medline]
26. Kuratomi, S., A. Kuratomi, K. Kuwahara, T. M. Ishii, K. Nakao, Y. Saito, and M. Takano. 2007. NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes. Biochem. Biophys. Res. Commun. 353:67-73.[CrossRef][Medline]
27. Kuwahara, K., Y. Saito, E. Ogawa, N. Takahashi, Y. Nakagawa, Y. Naruse, M. Harada, I. Hamanaka, T. Izumi, Y. Miyamoto, I. Kishimoto, R. Kawakami, M. Nakanishi, N. Mori, and K. Nakao. 2001. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell. Biol. 21:2085-2097.
28. Kuwahara, K., Y. Saito, M. Takano, Y. Arai, S. Yasuno, Y. Nakagawa, N. Takahashi, Y. Adachi, G. Takemura, M. Horie, Y. Miyamoto, T. Morisaki, S. Kuratomi, A. Noma, H. Fujiwara, Y. Yoshimasa, H. Kinoshita, R. Kawakami, I. Kishimoto, M. Nakanishi, S. Usami, M. Harada, and K. Nakao. 2003. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22:6310-6321.[CrossRef][Medline]
29. Langenickel, T., I. Pagel, K. Hohnel, R. Dietz, and R. Willenbrock. 2000. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am. J. Physiol. Heart Circ. Physiol. 278:H1500-H1506.
30. Lee, M. G., C. Wynder, D. A. Bochar, M. A. Hakimi, N. Cooch, and R. Shiekhattar. 2006. Functional interplay between histone demethylase and deacetylase enzymes. Mol. Cell. Biol. 26:6395-6402.
31. Lee, Y., A. J. Song, R. Baker, B. Micales, S. J. Conway, and G. E. Lyons. 2000. Jumonji, a nuclear protein that is necessary for normal heart development. Circ. Res. 86:932-938.
32. Leichter, M., and G. Thiel. 1999. Transcriptional repression by the zinc finger protein REST is mediated by titratable nuclear factors. Eur. J. Neurosci. 11:1937-1946.[CrossRef][Medline]
33. Lu, J. R., T. A. McKinsey, H. Xu, D. Z. Wang, J. A. Richardson, and E. N. Olson. 1999. FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors. Mol. Cell. Biol. 19:4495-4502.
34. Lunyak, V. V., R. Burgess, G. G. Prefontaine, C. Nelson, S. H. Sze, J. Chenoweth, P. Schwartz, P. A. Pevzner, C. Glass, G. Mandel, and M. G. Rosenfeld. 2002. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298:1747-1752.
35. Ma, K. K., K. Banas, and A. J. de Bold. 2005. Determinants of inducible brain natriuretic peptide promoter activity. Regul. Pept. 128:169-176.[CrossRef][Medline]
36. McBride, K., and M. Nemer. 2001. Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription. Can. J. Physiol. Pharmacol. 79:673-681.[CrossRef][Medline]
37. Milne, T. A., S. D. Briggs, H. W. Brock, M. E. Martin, D. Gibbs, C. D. Allis, and J. L. Hess. 2002. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10:1107-1117.[CrossRef][Medline]
38. Mukoyama, M., K. Nakao, K. Obata, M. Jougasaki, M. Yoshimura, E. Morita, K. Hosoda, S. Suga, Y. Ogawa, H. Yasue, et al. 1991. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem. Biophys. Res. Commun. 180:431-436.[CrossRef][Medline]
39. Nadeau, H., and H. A. Lester. 2002. NRSF causes cAMP-sensitive suppression of sodium current in cultured hippocampal neurons. J. Neurophysiol. 88:409-421.
40. Nakagawa, Y., K. Kuwahara, M. Harada, N. Takahashi, S. Yasuno, Y. Adachi, R. Kawakami, M. Nakanishi, K. Tanimoto, S. Usami, H. Kinoshita, Y. Saito, and K. Nakao. 2006. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J. Mol. Cell. Cardiol. 41:1010-1022.[CrossRef][Medline]
41. Nakamura, T., T. Mori, S. Tada, W. Krajewski, T. Rozovskaia, R. Wassell, G. Dubois, A. Mazo, C. M. Croce, and E. Canaani. 2002. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10:1119-1128.[CrossRef][Medline]
42. Naruse, Y., T. Aoki, T. Kojima, and N. Mori. 1999. Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc. Natl. Acad. Sci. USA 96:13691-13696.
43. Ogawa, E., Y. Saito, K. Kuwahara, M. Harada, Y. Miyamoto, I. Hamanaka, N. Kajiyama, N. Takahashi, T. Izumi, R. Kawakami, I. Kishimoto, Y. Naruse, N. Mori, and K. Nakao. 2002. Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression. Cardiovasc. Res. 53:451-459.
44. Ooi, L., N. D. Belyaev, K. Miyake, I. C. Wood, and N. J. Buckley. 2006. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression. J. Biol. Chem. 281:38974-38980.
45. Paquette, A. J., S. E. Perez, and D. J. Anderson. 2000. Constitutive expression of the neuron-restrictive silencer factor (NRSF)/REST in differentiating neurons disrupts neuronal gene expression and causes axon pathfinding errors in vivo. Proc. Natl. Acad. Sci. USA 97:12318-12323.
46. Pikkarainen, S., H. Tokola, R. Kerkela, T. Majalahti-Palviainen, O. Vuolteenaho, and H. Ruskoaho. 2003. Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors. J. Biol. Chem. 278:3969-3975.
47. Rivard, A., N. Principe, and V. Andres. 2000. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis. Cardiovasc. Res. 45:1026-1034.
48. Roopra, A., R. Qazi, B. Schoenike, T. J. Daley, and J. F. Morrison. 2004. Localized domains of g9a-mediated histone methylation are required for silencing of neuronal genes. Mol. Cell 14:727-738.[CrossRef][Medline]
49. Roopra, A., L. Sharling, I. C. Wood, T. Briggs, U. Bachfischer, A. J. Paquette, and N. J. Buckley. 2000. Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol. Cell. Biol. 20:2147-2157.
50. Rosati, B., F. Grau, and D. McKinnon. 2006. Regional variation in mRNA transcript abundance within the ventricular wall. J. Mol. Cell. Cardiol. 40:295-302.[CrossRef][Medline]
51. Rosenzweig, A., T. D. Halazonetis, J. G. Seidman, and C. E. Seidman. 1991. Proximal regulatory domains of rat atrial natriuretic factor gene. Circulation 84:1256-1265.
52. Saito, Y., K. Nakao, H. Arai, K. Nishimura, K. Okumura, K. Obata, G. Takemura, H. Fujiwara, A. Sugawara, T. Yamada, et al. 1989. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J. Clin. Investig. 83:298-305.[Medline]
53. Schoenherr, C. J., and D. J. Anderson. 1995. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267:1360-1363.
54. Shi, Y., F. Lan, C. Matson, P. Mulligan, J. R. Whetstine, P. A. Cole, R. A. Casero, and Y. Shi. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953.[CrossRef][Medline]
55. Shin, C. H., Z. P. Liu, R. Passier, C. L. Zhang, D. Z. Wang, T. M. Harris, H. Yamagishi, J. A. Richardson, G. Childs, and E. N. Olson. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110:725-735.[CrossRef][Medline]
56. Shiojima, I., I. Komuro, T. Oka, Y. Hiroi, T. Mizuno, E. Takimoto, K. Monzen, R. Aikawa, H. Akazawa, T. Yamazaki, S. Kudoh, and Y. Yazaki. 1999. Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J. Biol. Chem. 274:8231-8239.
57. Spicer, D. B., J. Rhee, W. L. Cheung, and A. B. Lassar. 1996. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272:1476-1480.[Abstract]
58. Tachibana, M., K. Sugimoto, T. Fukushima, and Y. Shinkai. 2001. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276:25309-25317.
59. Tapia-Ramirez, J., B. J. Eggen, M. J. Peral-Rubio, J. J. Toledo-Aral, and G. Mandel. 1997. A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. Proc. Natl. Acad. Sci. USA 94:1177-1182.